US20220105163A1 - PEPTIDE IMMUNOGENS TARGETING INTERLEUKIN 6 (IL-6) AND FORMULATIONS THEREOF FOR IMMUNOTHERAPY OF DISEASES IMPACTED BY IL-6 DYSREGULATION